December 09, 2005

Breast Cancer Drug Herceptin Halves Recurrence Risk

Calls for more women to be given the controversial breast cancer drug Herceptin were backed by further evidence of its effectiveness.

A new study showed that the drug reduces the risk of early stage aggressive breast cancer returning after treatment by up to 51%. (The Daily Mail)

Posted by news editor on December 9, 2005 04:41 AM